VYGR Voyager Therapeutics, Inc.
Healthcare$3.83+0.79%ClosedMarket Cap: $231.4M
As of 2026-05-26
Insider Statistics (Q2 2026)
Acquisitions
1
Dispositions
1
Buy/Sell Ratio
1.00
Net Shares
+38,489
Shares Acquired
50,000
Shares Disposed
11,511
Total Bought ($)
$0.00
Total Sold ($)
$1.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Mon May 18 | Quinlan Amy | officer: Principal Accounting Officer | Sell | 50,000 | $5.28 | 0 |
| Mon May 18 | Quinlan Amy | officer: Principal Accounting Officer | Sell | 28,500 | $3.68 | 0 |
| Mon May 18 | Quinlan Amy | officer: Principal Accounting Officer | Sell | 0 | $0.00 | 36,749 |
| Fri Apr 03 | Shiferman Gregory L. | officer: SVP and General Counsel | Sell | 50,000 | $0.00 | 50,000 |
| Fri Apr 03 | Sandrock Alfred | director, officer: President and CEO | Sell | 11,511 | $3.87 | 472,549 |
| Thu Feb 26 | Swartz Robin | officer: COO & CBO | Sell | 6,458 | $3.77 | 199,738 |
| Thu Feb 26 | Sandrock Alfred | director, officer: President and CEO | Sell | 14,197 | $3.79 | 484,060 |
| Thu Feb 26 | Jorgensen Nathan D. | officer: Chief Financial Officer | Sell | 4,668 | $3.77 | 151,416 |
| Thu Feb 26 | Carter Todd Alfred | officer: Chief Scientific Officer | Sell | 4,174 | $3.76 | 145,718 |
| Fri Feb 20 | Swartz Robin | officer: COO & CBO | Sell | 3,882 | $3.44 | 206,196 |
| Fri Feb 20 | Sandrock Alfred | director, officer: President and CEO | Sell | 11,732 | $3.41 | 498,257 |
| Fri Feb 20 | Carter Todd Alfred | officer: Chief Scientific Officer | Sell | 3,301 | $3.44 | 149,892 |
| Wed Feb 11 | Swartz Robin | officer: COO & CBO | Sell | 4,569 | $3.85 | 210,078 |
| Wed Feb 11 | Sandrock Alfred | director, officer: President and CEO | Sell | 12,192 | $3.78 | 509,989 |
| Wed Feb 11 | Carter Todd Alfred | officer: Chief Scientific Officer | Sell | 3,525 | $3.85 | 153,193 |